GlaxoSmithKline is seeking regulatory approval for the world’s first vaccine against malaria, after promising trial data showed that it cut cases of the often-fatal disease in African children.
The company has been developing the vaccine for 3 decades and plans to submit a regulatory application to the European Medicines Agency.
Malaria kills hundreds of thousands of people every year.
Photo: Malaria infected mosquitoes (AFP)
